Adrenal imaging agents: Rationale, synthesis, formulation and, metabolism
- 31 January 1978
- journal article
- Published by Elsevier in Seminars in Nuclear Medicine
- Vol. 8 (1) , 5-21
- https://doi.org/10.1016/s0001-2998(78)80004-x
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Detection of Metastatic Adrenal Carcinoma Using131I-6-β-Iodomethyl-19-Norcholesterol Total Body ScansJournal of Clinical Endocrinology & Metabolism, 1977
- A New and Superior Adrenal Imaging Agent,131I-6ß-Iodomethyl-19-Nor-Cholesterol (NP-59): Evaluation in HumansJournal of Clinical Endocrinology & Metabolism, 1977
- Uptake of131I-19-iodocholesterol by an adrenal cortical carcinoma and its metastasesJournal of Clinical Endocrinology & Metabolism, 1976
- Homoallylic rearrangement of 19-iodocholesterolJournal of the Chemical Society, Chemical Communications, 1975
- Synthesis of a new adrenal cortex imaging agent 6β-131 I-iodomethyl-19-nor cholest -5(10)-en-3β-ol (NP-59)Journal of Labelled Compounds and Radiopharmaceuticals, 1975
- Lipid composition of membranes of aminestorage organellesBiochemical Journal, 1972
- Diagnosis of Adrenal Disease by Visualization of Human Adrenal Glands with131I-19-IodocholesterolNew England Journal of Medicine, 1971
- Tumor localizing agents. IX. Radioiodinated cholesterolSteroids, 1970
- Lipids of the adrenal medulla. Lysolecithin, a characteristic constituent of chromaffin granulesBiochemical Journal, 1967
- Cholesterol Ester MetabolismPhysiological Reviews, 1965